Financials

Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2561
DSGN
Design Therapeutics, Inc. - Common Stock
13.86 USD-8.76%-7.41%+24.98%+248.24%865.65 M USD
2588
REPL
Replimune Group, Inc. - Common Stock
9.94 USD-9.55%-14.38%+12.83%-13.34%834.41 M USD
2609
CTMX
CytomX Therapeutics, Inc. - Common Stock
3.70 USD-1.60%-3.90%+21.31%+56.12%805.50 M USD
2632
ZVRA
Zevra Therapeutics, Inc. - Common Stock
13.18 USD-1.27%-5.79%+2.89%+23.87%779.14 M USD

Noticias